THBS1 and diabetes mellitus: The treatment of SMCs with an anti-TSP1 antibody and a TSP1 siRNA reverses their proliferation, thereby suggesting a direct link between the hexosamine catabolic pathway, glycosylation, and TSP1 in diabetes (36, 67).